Lack of TSH stimulation in patients with differentiated thyroid cancer - Possible causes

Wspolczesna Onkologia

Volumn 16, Issue 3, 2012, Pages 273-275

  Gut, Paweł ^a   Matysiak Grześ, Magdalena ^a   Fischbach, Jakub ^a   Klimowicz, Aleksandra ^a   Gryczyńska, Maria ^a   Ruchała, Marek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Differentiated thyroid cancer; TSH stimulation

Indexed keywords

BROMOCRIPTINE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CASE REPORT; DIFFERENTIATED THYROID CANCER; FEMALE; HISTOPATHOLOGY; HOSPITAL READMISSION; HUMAN; HYSTERECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY TERATOMA; THYROGLOBULIN BLOOD LEVEL; THYROTROPIN BLOOD LEVEL;

EID: 84865092096     PISSN: 14282526     EISSN: None     Source Type: Journal    
DOI: 10.5114/wo.2012.29299     Document Type: Article

References (11)

1. Salman WD, Singh M, Twaij Z. A case of papillary thyroid carcinoma in struma ovarii and review of the literature. Patholog Res Int 2010; 2010: 352476.
2. Devaney R, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. International J Gynecol Path 1993; 12: 333-343.
3. Makani S, Kim W, Gaba AR. Struma ovarii with a focus of papillary thyroid cancer: a case report and review of the literature. Gynecol Oncol 2004; 94: 835-839.
4. Alvarez DM, Lee V, Bhatt S. Struma ovarii with papillary thyroid carcinoma. J Clin Imaging Sci 2011; 1: 44.
5. Guanipa Sierra W, Fernandez Catalina P, Alvarez Martinez M. Struma ovarii wiyh malignant histology: a case of papillary thyroid carcinoma. Endocrinol Nutr 2011; 58: 48-50.
6. Jammah AA, Driedrger A, Rachinski I. Incidental finding of ovarian teratoma on post-therapy scan for papillary thyroid cancer and impact of SPECT/CT imaging. Arq Bras Endocrinol Metabol 2011; 55: 490-3.
7. Morganstein D, Mendoza N, Strickland N. Low TSH in a patient with primary hypothyroidism. J R Soc Med 2005; 98: 417-8.
8. Watt A, Pobereskin L, Vaidya B. Pituitary apoplexy within a macroprolactinoma. Nat Clin Pract Endocrinol Metab 2008; 4: 635-41.
9. Holmes GI, Shepherd P, Walker JD. Panhypopituitarism secondary to a macroprolactinoma manifesting with pancytopenia; case report and literature review. Endocr Pract 2011; 17: 32-6.
10. Ringel MD, Ladenson PW. Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism. J Clin Endocrinol Metab 1996; 81: 1724-5.
11. Kars M, Pareira AM, Smith JW. Long-term outcome of patients with macroprolactinomas initialy treated with dopamine agonists. Eur J Intern Med 2009; 4: 387-93.